Genomic profiles of de novo high and low-volume metastatic prostate cancer: Results from a 2-stage feasibility and prevalence study in the STAMPEDE trial

Clare Gilson, Fiona Ingleby, Duncan C. Gilbert, Marina A. Parry, Nafisah B. Atako, Adnan Ali, Alex Hoyle, Noel W. Clarke, Melissa Gannon, Chris Wanstall, Christopher Brawley, Malcolm D. Mason, Zafar Malik, Andrew Simmons, Andrea Loehr, Alison Parry-Jones, Rosalind Eeles, Zsofia Kote-Jarai, Nicholas D. James, Claire AmosMahesh K.B. Parmar, Ruth E. Langley, Matthew R. Sydes, Gerhardt Attard*, Simon Chowdhury

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Genomic profiles of de novo high and low-volume metastatic prostate cancer: Results from a 2-stage feasibility and prevalence study in the STAMPEDE trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology